Clinical Trial Update: A Study of Daratumumab in Japanese Participants With Relapsed or Refractory Multiple Myeloma [Phase 1]

View source ↗

Summary

This clinical trial update reports the results of a Phase 1 study of daratumumab in Japanese participants with relapsed or refractory multiple myeloma. The tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DARZALEX (daratumumab)

Snippet

Sponsor: Janssen Pharmaceutical K.K. | Conditions: Multiple Myeloma | Phase 1 | Status: COMPLETED